Sun Pharmaceutical Industries Inc. has voluntarily recalled 4,608 bottles of Clonazepam Orally Disintegrating Tablets, USP (0.125 mg). The recall was initiated because an oversized tablet was discovered in a bottle. This prescription medication is used to treat seizures and panic disorders. No injuries or incidents have been reported in connection with this issue.
An oversized tablet may contain a higher dosage of medication than intended. Ingesting a higher dose than prescribed can lead to unintentional side effects or medical complications associated with clonazepam.
You have 2 options:
Manufactured by Sun Pharmaceutical Industries Ltd. Mumbai, India; Distributed by Sun Pharmaceutical Industries Inc., Cranbury, NJ.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.